Effective as of September 28, 2023, the Board of Directors (the ?Board?) of Tengjun Biotechnology Corp. (the ?Company?) removed Caihong Qu as the interim CEO a of the Company. Effective as of September 28, 2023, the Board appointed Ruiming Zhou as the CEO of the Company, until the next annual meeting of the Company?s stockholders, and until his successor is elected and qualified or until his prior death, resignation or removal.

Mr. Ruiming Zhou, age 56, graduated from the First Vocational School of Ba Meng, Inner Mongolia. Since June 2017, he has served as a director at Shandong Tengjunxiang Biotechnology Co. Ltd. Mr. Zhou is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Zhou and any other persons pursuant to which he was appointed as Director of the Company.